Site-specific methylation patterns of theGALandGALR1/2genes in head and neck cancer: Potential utility as biomarkers for prognosis

Novel Insights into Head and Neck Cancer using Next-Generation "Omic" Technologies

(2015) L. Sepiashvili et al.   CANCER RESEARCH

Epigenetic inactivation of galanin and GALR1/2 is associated with early recurrence in head and neck cancer

(2015) Kiyoshi Misawa et al.   CLINICAL & EXPERIMENTAL METASTASIS

Galanin receptors as a potential target for neurological disease

(2015) Krista Freimann et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Promoter Hypermethylation Profiling Identifies Subtypes of Head and Neck Cancer with Distinct Viral, Environmental, Genetic and Survival Characteristics

(2015) Javed Hussain Choudhury et al.   PLoS One

Recent Progress in Therapeutic Treatments and Screening Strategies for the Prevention and Treatment of HPV-Associated Head and Neck Cancer

(2015) Sonia Whang et al.   Viruses-Basel

G-Protein-Coupled Receptors: Next Generation Therapeutic Targets in Head and Neck Cancer?

(2015) Takeharu Kanazawa et al.   Toxins

Emerging biomarkers in head and neck cancer in the era of genomics

(2014) Hyunseok Kang et al.   Nature Reviews Clinical Oncology

Methylation as a biomarker for head and neck cancer

(2014) L.M.R.B. Arantes et al.   ORAL ONCOLOGY

Tumor-suppressor Gene Promoter Hypermethylation in Saliva of Head and Neck Cancer Patients

(2014) Dmitry A. Ovchinnikov et al.   Translational Oncology

Tumor suppressor activity and inactivation of galanin receptor type 2 by aberrant promoter methylation in head and neck cancer

(2013) Yuki Misawa et al.   CANCER

Unique DNA Methylation Loci Distinguish Anatomic Site and HPV Status in Head and Neck Squamous Cell Carcinoma

(2013) R. A. Lleras et al.   CLINICAL CANCER RESEARCH

GALR1 Methylation in Vaginal Swabs Is Highly Accurate in Identifying Women With Endometrial Cancer

(2013) Konstantinos Doufekas et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Frequent promoter hypermethylation of tachykinin-1 and tachykinin receptor type 1 is a potential biomarker for head and neck cancer

(2013) Kiyoshi Misawa et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Epstein-Barr Virus Infection as an Epigenetic Driver of Tumorigenesis

(2012) A. Kaneda et al.   CANCER RESEARCH

Identification of Galanin and Its Receptor GalR1 as Novel Determinants of Resistance to Chemotherapy and Potential Biomarkers in Colorectal Cancer

(2012) L. Stevenson et al.   CLINICAL CANCER RESEARCH

Ligand binding properties of human galanin receptors

(2012) Wiktor Jurkowski et al.   MOLECULAR MEMBRANE BIOLOGY

Complex Etiology Underlies Risk and Survival in Head and Neck Cancer Human Papillomavirus, Tobacco, and Alcohol: A Case for Multifactor Disease

(2012) Elaine M. Smith et al.   Journal of Oncology

Genome-wide methylation and expression differences in HPV(+) and HPV(-) squamous cell carcinoma cell lines are consistent with divergent mechanisms of carcinogenesis

(2011) Maureen A. Sartor et al.   Epigenetics

Genome-wide identification of possible methylation markers chemosensitive to targeted regimens in colorectal cancers

(2011) Jin C. Kim et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Tobacco and alcohol use increases the risk of both HPV-associated and HPV-independent head and neck cancers

(2010) Elaine M. Smith et al.   CANCER CAUSES & CONTROL

Galanin receptor subtypes 1 and 2 as therapeutic targets in head and neck squamous cell carcinoma

(2010) Takeharu Kanazawa et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

G protein-coupled receptors: novel targets for drug discovery in cancer

(2010) Rosamaria Lappano et al.   NATURE REVIEWS DRUG DISCOVERY

Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC)

(2010) Farshid Dayyani et al.   Head and Neck Optical Diagnostics Society

Galanin Receptor Subtype 2 Suppresses Cell Proliferation and Induces Apoptosis in p53 Mutant Head and Neck Cancer Cells

(2009) T. Kanazawa et al.   CLINICAL CANCER RESEARCH

Epigenetic Inactivation of Galanin Receptor 1 in Head and Neck Cancer

(2008) K. Misawa et al.   CLINICAL CANCER RESEARCH

Identification of Novel Tumor Markers in Prostate, Colon and Breast Cancer by Unbiased Methylation Profiling

(2008) Woonbok Chung et al.   PLoS One